Magnetic Resonance Spectroscopy in Clinical Oncology

@article{Golder2004MagneticRS,
  title={Magnetic Resonance Spectroscopy in Clinical Oncology},
  author={W. Golder},
  journal={Oncology Research and Treatment},
  year={2004},
  volume={27},
  pages={304 - 309}
}
  • W. Golder
  • Published 2004
  • Medicine
  • Oncology Research and Treatment
The combination of magnetic resonance spectroscopy (MRS) and imaging (MRI) has led to mapping metabolites from normal and neoplastic tissue within the time limits of a routine study. MRSI (magnetic resonance spectroscopy imaging) detects metabolites that contain protons, phosphorus, fluorine, or other nuclei. The uniqueness of the information available in vivo and in a non-invasive manner encouraged radiologists and oncologists to apply MRSI in research and clinical practice. Both 1H- and 31P… Expand
View on PubMed
doi.org
27 Citations
Highly Influential Citations
2
Background Citations
12
Methods Citations
3

27 Citations

Citation Type

Citation Type

In vivo magnetic resonance spectroscopy in cancer.
Feasibility of In vivo Proton Magnetic Resonance Spectroscopy for Lung Cancer
Metabolic brain imaging by magnetic resonance
Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T
Clinical 1h magnetic resonance spectroscopy of brain metastases at 1.5T and 3T
Imaging of brain tumors: MR spectroscopy and metabolic imaging.
In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods.
Investigation of compressed-sensing for acceleration of magnetic resonance spectroscopic imaging
Utilization of advanced imaging technologies for target delineation in radiation oncology.
...
1
2
3
...

References

SHOWING 1-10 OF 46 REFERENCES
In Vivo Proton (H1) Magnetic Resonance Spectroscopy for Cervical Carcinoma
The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors
Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology.
Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.
  • K. Warren, J. Frank, +6 authors F. Balis
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.
Tumor metabolism: the lessons of magnetic resonance spectroscopy.
MR spectroscopy of musculoskeletal soft-tissue tumors.
  • W. Negendank
  • Medicine
  • Magnetic resonance imaging clinics of North America
  • 1995
MR spectroscopy of musculoskeletal soft-tissue tumors.
...
1
2
3
4
5
...